Companies › BJDX
BLUEJAY DIAGNOSTICS INC (BJDX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001704287 · EDGAR filings · Updated 2026-07-22
BLUEJAY DIAGNOSTICS INC (BJDX) has reported institutional ownership of 6.1%, with 6 institutional managers holding positions valued at $108.2K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (3)
- 2026-07-22 — Current report (8-K) filed
- 2026-07-22 — Insider transaction reported (Form 4)
- 2026-07-22 — Initial insider ownership filed (Form 3)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-13 — Insider transaction reported (Form 4)
- 2026-07-13 — Initial insider ownership filed (Form 3)
- 2026-07-10 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BLUEJAY DIAGNOSTICS INC has 6 institutional holders and institutional ownership of 6.1%.
Data flags from SEC filings
Related companies
ZOMEDICA CORP COM (ZOMDF) · Alzamend Neuro Inc (ALZN) · Bio Green Med Solution Inc (BGMS) · Enveric Biosciences Inc (ENVB) · ORAGENICS INC (OGEN) · Glucotrack Inc (GCTK)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-22.